Does USTEKINUMAB Cause Facial paralysis? 111 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Facial paralysis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.1% of all adverse event reports for USTEKINUMAB.
111
Reports of Facial paralysis with USTEKINUMAB
0.1%
of all USTEKINUMAB reports
1
Deaths
31
Hospitalizations
How Dangerous Is Facial paralysis From USTEKINUMAB?
Of the 111 reports, 1 (0.9%) resulted in death, 31 (27.9%) required hospitalization.
Is Facial paralysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 111 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Facial paralysis?
ADALIMUMAB (382)
ONABOTULINUMTOXINA (305)
METHOTREXATE (304)
NIVOLUMAB (171)
ETANERCEPT (169)
RITUXIMAB (151)
SECUKINUMAB (140)
PREDNISONE (139)
ASPIRIN (127)
FINGOLIMOD (121)
Which USTEKINUMAB Alternatives Have Lower Facial paralysis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE